APA (7th ed.) Citation

Piermattei, A., De Luca, R., Peissert, F., Plüss, L., Puca, E., D'Alessandris, N., . . . Nero, C. (2025). A comparative analysis of tumor markers reveals EDA fibronectin as a promising target in high-grade serous ovarian cancer. Journal of Ovarian Research, 18(1), 1. https://doi.org/10.1186/s13048-025-01772-6

Chicago Style (17th ed.) Citation

Piermattei, Alessia, et al. "A Comparative Analysis of Tumor Markers Reveals EDA Fibronectin as a Promising Target in High-grade Serous Ovarian Cancer." Journal of Ovarian Research 18, no. 1 (2025): 1. https://doi.org/10.1186/s13048-025-01772-6.

MLA (9th ed.) Citation

Piermattei, Alessia, et al. "A Comparative Analysis of Tumor Markers Reveals EDA Fibronectin as a Promising Target in High-grade Serous Ovarian Cancer." Journal of Ovarian Research, vol. 18, no. 1, 2025, p. 1, https://doi.org/10.1186/s13048-025-01772-6.